Floyd Petersen - Mar 1, 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Mar 1, 2023
Transactions value $
-$18,349
Form type
4
Date filed
3/2/2023, 06:33 PM
Previous filing
Feb 2, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Sale -$34 -1 0% $33.70 86.1K Mar 1, 2023 Direct F1
transaction AMPH Common Stock Sale -$15.1K -412 -0.48% $36.59 85.7K Mar 1, 2023 Direct F1, F2
transaction AMPH Common Stock Sale -$3.24K -87 -0.1% $37.25 85.6K Mar 1, 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.11 to $36.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.13 to $37.355, inclusive.